RiverGlades Family Offices’s CVS Health CVS Stock Holding History

RiverGlades Family Offices’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-6,200	Closed	-$390K	–	84
2024 Q3	$390K	Hold	6,200	–	–	0.28%	56
2024 Q2	$366K	Hold	6,200	–	–	0.28%	57
2024 Q1	$345K	Hold	6,200	–	–	0.28%	56
2023 Q4	$479K	Hold	6,200	–	–	0.39%	44
2023 Q3	$433K	Sell	6,200 -400	-6%	-$28.3K	0.38%	41
2023 Q2	$456K	Buy	6,600 +700	+12%	+$49.8K	0.41%	41
2023 Q1	$438K	Hold	5,900	–	–	0.4%	41
2022 Q4	$550K	Buy	+5,900	New	+$569K	0.51%	34
2022 Q2	$547K	Hold	5,900	–	–	0.51%	36
2022 Q1	$597K	Hold	5,900	–	–	0.45%	41
2021 Q4	$609K	Sell	5,900 -750	-11%	-$69.3K	0.44%	41
2021 Q3	$564K	Hold	6,650	–	–	0.44%	38
2021 Q2	$555K	Hold	6,650	–	–	0.43%	39
2021 Q1	$500K	Hold	6,650	–	–	0.41%	39
2020 Q4	$454K	Buy	6,650 +150	+2%	+$9.76K	0.39%	43
2020 Q3	$380K	Buy	6,500 +1,000	+18%	+$62.2K	0.36%	43
2020 Q2	$357K	Hold	5,500	–	–	0.37%	46
2020 Q1	$326K	Buy	+5,500	New	+$367K	0.35%	47
2018 Q1	–	Sell	-2,815	Closed	-$204K	–	81
2017 Q4	$204K	Buy	+2,815	New	+$205K	0.17%	68

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

RiverGlades Family Offices's CVS Position: Q4 2024 in Review

RiverGlades Family Offices sold out of CVS Health (CVS) in Q4 2024, closing a stake of 6,200 shares — an estimated $390K sold.

RiverGlades Family Offices first reported a position in CVS in Q4 2017 and held it in 19 quarters. The position peaked at $609K in Q4 2021. 1,668 funds tracked by Wall St. Rank hold CVS as of Q4 2024.

RiverGlades Family Offices reported no remaining CVS Health position as of Q4 2024 after selling out during the quarter.
RiverGlades Family Offices sold 6,200 CVS Health shares in Q4 2024, an estimated $390K.
RiverGlades Family Offices first reported a position in CVS Health in Q4 2017 and held it in 19 quarters.
RiverGlades Family Offices's CVS Health position peaked at $609K in Q4 2021.
1,668 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.

Based on RiverGlades Family Offices's 13F filing for Q4 2024, filed 13 Feb 2025.